Fetal growth restriction (FGR) is defined as a pathological in utero growth disorder primarily caused by factors related to ...

This classification of the disease is the result of immune-mediated destruction of more than 90% of the adrenal cortex and ...

Keywords: comorbidities, primary aldosteronism, MACS, Cushing syndrome, pheochromocytoma, cardiovascular risk, adrenal incidentalomas, CAH Important Note: All contributions to this Research Topic must ...

Foscenvivint is under clinical development by Eisai and currently in Phase I for Adrenocortical Carcinoma (Adrenal Cortex Cancer). According to GlobalData, Phase I drugs for Adrenocortical Carcinoma ...

ADCT-701 is under clinical development by ADC Therapeutics and currently in Phase I for Adrenocortical Carcinoma (Adrenal Cortex Cancer). According to GlobalData, Phase I drugs for Adrenocortical ...

Glucocorticoids (GCs) show prominent circadian rhythms controlled by an interplay of clocks in the suprachiasmatic nuclei and the adrenal cortex. They serve as synchronizers of other tissue clocks ...

Bergenstal, D. M., Lipsett, M. B., Moy, R. H., and Hertz, R. (personal communication submitted for publication). Bleiberg, M. J., Ph.D. thesis, University of Virginia ...

At least partial autonomy of cortisol production (either direct from the adrenal cortex or secondary to adrenocorticotropic hormone secretion) Failure to suppress cortisol levels below 50 nmol/l ...

Albright's disease, exceptional cases of tumor of the adrenal cortex, granulosa-cell tumor of the ovary and, very exceptionally, chorioncarcinomatous teratoma of the ovary. The observation of ...

Most tumors of the adrenal glands are benign (not cancer). Adrenal cancer is very rare. At Fred Hutch, our endocrine tumor specialists — all UW Medicine doctors — have experience evaluating and ...

Sep. 20, 2024 — The incidence of stroke continues to increase for adults and children living with sickle cell disease (SCD) despite the Stroke Prevention Trial in ... Sep. 13, 2024 — When a ...